Search
Menu
Cognex Corp. - Smart Sensor 3-24 GIF LB

Summit Subsidiary Gets Approval to Test Vision System

Facebook X LinkedIn Email
WALTHAM, Mass., July 30 -- Summit Technology Inc. reports that its Autonomous Technologies subsidiary has been granted an Investigational Device Exemption by the US Food and Drug Administration. The company will begin studying the feasibility of performing customized ablations using a combination of its patented CustomCornea measurement device and its LADARVision System. The CustomCornea technology was designed to enable surgeons to treat ocular aberrations that cannot be detected or compensated for using existing refractive systems. Summit's study will include the treatment of myopia,...Read full article

Related content from Photonics Media

    Published: July 1999
    News & Features

    We use cookies to improve user experience and analyze our website traffic as stated in our Privacy Policy. By using this website, you agree to the use of cookies unless you have disabled them.